Ubrelvy 50 mg tablets contain ubrogepant, a CGRP receptor antagonist used for the acute treatment of migraine attacks with or without aura in adults./Description: Ubrelvy (ubrogepant) is an oral medication indicated for the acute treatment of migraine attacks with or without aura in adults. It belongs to the class of calcitonin gene-related peptide (CGRP) receptor antagonists, which work by blocking the activity of CGRP, a protein involved in migraine attacks. Ubrelvy is not intended for the preventive treatment of migraines.. Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
